Bile Duct Cancer
What's New
Last Posted: Jun 04, 2019
- Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano Stephen et al. Nature 2019 May - Cancer disparities
- Mutation analysis and copy number changes of KRAS and BRAF genes in Taiwanese cases of biliary tract cholangiocarcinoma.
Huang Wen-Chih, et al. Journal of the Formosan Medical Association = Taiwan yi zhi 2016 10 - Variants in motilin, somatostatin and their receptor genes and risk of biliary tract cancers and stones in Shanghai, China.
Xu Hong-Li, et al. Meta gene 2014 12 418-426 - Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility.
Zimmer Vincent, et al. Oncology letters 2012 7 (1) 101-106 - Bile duct cancer
From NCATS Genetic and Rare Diseases Information Center - Cholesterol metabolism gene polymorphisms and the risk of biliary tract cancers and stones: a population-based case-control study in Shanghai, China.
Xu Hong-Li, et al. Carcinogenesis 2011 1 (1) 58-62 - Androgen receptor CAG repeat length and risk of biliary tract cancer and stones.
Meyer Tamra E, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 3 (3) 787-93 - Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.
Park Sue K, et al. Carcinogenesis 2010 5 (5) 842-6 - Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
Hoblinger A, et al. Digestion 2009 0 (1) 36-9
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Sep 27, 2021
- Content source: